Z-Medica

INTERNATIONAL

The Power to Stop Bleeding Throughout the World

A key part of Z-Medica's near-term growth strategy is developing markets on a worldwide scale. We are committed to making Z-Medica a global leader in hemorrhage control. Building our sales and support structures to meet the diverse needs of markets on every continent will make our products the preferred hemostatic devices worldwide.

QuikClot: Delivery of an Effective Hemostatic Agent
As the recommended hemostatic dressing for the U.S. Military, more than five million units of QuikClot Combat Gauze have been deployed since 2008. QuikClot is also used throughout the world in hospitals, law enforcement, disaster recovery and first responder kits, making QuikClot a key component of hemorrhage control solutions everywhere.

QuikClot devices use a proprietary methodology to impregnate gauze with kaolin, an inorganic mineral that accelerates the body’s natural clotting ability1 and produces no exothermic reaction. Since QuikClot does not contain animal proteins, human proteins, shellfish or botanicals, hemostasis can be achieved without worry of instigating an allergic response.4,5

Novacol: Resorbable Collagen Clotting Device
Z-Medica purchased the Novacol brand in 2014 to help deliver on its strategy to strengthen its position as a worldwide leader in bleeding control.

Novacol products are available in the European Union and Korea. They are primarily used to control bleeding during surgery. Novacol adheres to the bleeding surface and provides a matrix for platelets to aggregate to form a clot.2,3 The devices can be left in the body without the risk of allergic reaction.4 Novacol is fully resorbed after about six (6) weeks.5

1. Trabattoni D, Montorsi P, Fabbiocchi F, Lualdi A, Gatto P, Bartorelli A. A new kaolin-based haemostatic bandage compared with manual compression for bleeding control after percutaneous coronary procedures. Eur Radiol. 2011;21:1687-1691.
2. Wheat JC, Wolf, JS Jr. Advances in Bioadhesives, Tissue Sealants, and Hemostatic Agents. Urol Clin N Am. 2009;36:265-275.
3. Schreiber MA, Neveleff, DJ. Achieving Hemostasis With Topical Hemostats: Making Clinically and Economically Appropriate Decisions in the Surgical and Trauma Setting. AORN Journal. 2011;94.5:S4-S20.
4. Chvapil M, Chvapil TA. Antigenicity of Hemostatic Collagen Fleece in Rabbits. Jpn Pharmacol Ther. 1990;18.8:49-56.
5. Chvapil M. Tissue Reaction and Biodegradation of Implanted Hemostatic Collagen Fleece in Rats. Jpn Pharmacol Ther. 1990;18.10:179-192.

15.June.2015

Z-Medica® and OxySure Sign Distribution Agreement

Wallingford, CT, June 15, 2015 – Z-Medica® LLC, a leading developer and marketer of hemostatic devices, announces today that they have signed a distribution agreement with OxySure Systems, Inc. (OTCQB: OXYS), a global leader and innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology and other innovative medical device solutions, to sell QuikClot® products to their customers.

READ MORE ›

03.June.2015

Z-Medica® Commends Tucson Police Department for Trauma Kit Utilization

Wallingford, CT, June 3, 2015 – Z-Medica®, LLC, a leading developer and marketer of hemostatic devices, announces today since June has been designated as National Safety Month by the National Safety Council, the Company commends the Tucson, AZ. Police Department for its commitment to public safety.

READ MORE ›

VISIT OUR PRODUCT SITE

Quikclot
Click Here
All trademarks herein are registered trademarks of their respective owners. ©2015 Z-Medica, LLC.
All rights reserved.